75 related articles for article (PubMed ID: 3175920)
1. [13 years' experience with the combined treatment of lymphogranulomatosis].
Fokina NT
Ter Arkh; 1988; 60(5):111-8. PubMed ID: 3175920
[TBL] [Abstract][Full Text] [Related]
2. [Combination chemotherapy with total or subtotal lymphatic irradiation in the treatment of lymphogranulomatosis, stage IIIA or IIIB (based on five- and ten-year results)].
Kanaev SV; Gershanovich ML; Malinin AP
Vopr Onkol; 1997; 43(1):32-8. PubMed ID: 9133084
[TBL] [Abstract][Full Text] [Related]
3. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
[TBL] [Abstract][Full Text] [Related]
4. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
[TBL] [Abstract][Full Text] [Related]
5. [3-year results of the combined treatment of stage I and II lymphogranulomatosis patients].
Baĭsogolov GD; Shakhtarina SV
Med Radiol (Mosk); 1984 Apr; 29(4):46-50. PubMed ID: 6546966
[TBL] [Abstract][Full Text] [Related]
6. [The polychemotherapy and combined treatment of patients with stage-I and -II lymphogranulomatosis and unfavorable prognosis].
Demina EA; Kaverzneva MM; Kondrat'eva NF; Agafonov VA
Ter Arkh; 1990; 62(7):72-5. PubMed ID: 2251669
[TBL] [Abstract][Full Text] [Related]
7. [The efficacy of treatment using expanded programs of megavolt irradiation and polychemotherapy in patients with lymphogranulomatosis in stages I, II and IIIA].
Mendeleev IM; Oleĭnik VA; Miasnikov AA; Polezhaev IuN
Ter Arkh; 1990; 62(7):67-70. PubMed ID: 2123574
[TBL] [Abstract][Full Text] [Related]
8. [Ten-year outcomes of lymphogranulomatosis treatment according to the protocol MOPP-ABVD+radiotherapy].
Pivnik AV; Rastrigin NA; Moiseeva TN; Lutsenko IN; Dudarova RG; Shavlokhov VS; Efimov IV; Kozhurin SV; Shitareva IV; Gemdzhian EG; Tsyba NN; Kolosova LIu; Melikian AL; Skidan NI; Pan'shin GA; Sotnikov VM; Dotsenko PV; Nechistiuk AV
Ter Arkh; 2006; 78(8):57-62. PubMed ID: 17078219
[TBL] [Abstract][Full Text] [Related]
9. Pediatric Hodgkin's disease.
Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
[TBL] [Abstract][Full Text] [Related]
10. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Mjaaland I; Ganser D; Freitag EM; Bohndorf W
Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
[TBL] [Abstract][Full Text] [Related]
11. [Is irradiation of intact ileoinguinal lymph nodes necessary in radiochemotherapy for stage-III Hodgkin's disease?].
Kanaev SV; Girshovich MM; Golovanov SG; Gershanovich ML
Vopr Onkol; 2007; 53(4):453-5. PubMed ID: 17969410
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of combined treatment of stage III(B) Hodgkin's disease].
Kanaev SV; Golovanov SG; Girshovich MM; Gershanovich ML
Vopr Onkol; 2006; 52(5):525-30. PubMed ID: 17168360
[TBL] [Abstract][Full Text] [Related]
13. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
14. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
Arranz R; Gil-Fernández JJ; Muñoz E; Acevedo A; Sobrino MP; Fernández-Rañada JM
Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of efficacy of chemoradiotherapy for Hodgkin's disease].
Kanaev SV; Gershanovich ML; Pozharisskiĭ KM; Girshovich MM; Malinin AP; Golovanov SG
Vopr Onkol; 2004; 50(6):652-7. PubMed ID: 15755057
[TBL] [Abstract][Full Text] [Related]
16. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
17. Second malignant tumours in childhood Hodgkin's disease.
Jenkin D; Greenberg M; Fitzgerald A
Med Pediatr Oncol; 1996 Jun; 26(6):373-9. PubMed ID: 8614372
[TBL] [Abstract][Full Text] [Related]
18. [Experience with a new "reserve protocol" in advanced and pretreated Hodgkin's disease].
István L; Marton E
Orv Hetil; 1989 Dec; 130(52):2791-6. PubMed ID: 2691951
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the efficacy of radiotherapy in the combined treatment of generalized Hodgkin's disease in children].
Tsyplenkov VG; Sviridova AV
Med Radiol (Mosk); 1984 Oct; 29(10):34-7. PubMed ID: 6548787
[TBL] [Abstract][Full Text] [Related]
20. [Role of radiotherapy in the treatment of stage IIIB Hodgkin's disease in children].
Kanaev SV; Kolygin BA; Malinin AP; Chikrizov SI
Med Radiol (Mosk); 1987 May; 32(5):13-5. PubMed ID: 3586916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]